Haddad, Robert
Dana-Farber Cancer Institute
7 papers on CoChatORCID 0000-0003-1413-0079
Most cited papers
- Verified
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
Ferris, R. L., Blumenschein, G., Fayette, J., Guigay, J., Colevas, A. D., Licitra, L., Harrington, K., Kasper, S., Vokes, E. E., Even, C., et al. (2016) · New England Journal of Medicine
Head and Neck Cancer StudiesCancer Immunotherapy and Biomarkers
Cited by 5,101
- Verified
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
Lee, N. Y., Ferris, R. L., Psyrri, A., Haddad, R. I., Tahara, M., Bourhis, J., Harrington, K., Chang, P. M.-H., Lin, J.-C., Razaq, M. A., et al. (2021) · The Lancet Oncology
Head and Neck Cancer StudiesCancer Immunotherapy and Biomarkers
Cited by 661
- Verified
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
Miao, D., Margolis, C. A., Vokes, N. I., Liu, D., Taylor-Weiner, A., Wankowicz, S. M., Adeegbe, D., Keliher, D., Schilling, B., Tracy, A., et al. (2018) · Nature Genetics
Cancer Immunotherapy and BiomarkersCancer Genomics and Diagnostics
Cited by 620
- Verified
Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations
Ho, A. L., Brana, I., Haddad, R., Bauman, J., Bible, K., Oosting, S., Wong, D. J., Ahn, M.-J., Boni, V., Even, C., et al. (2021) · Journal of Clinical Oncology
Head and Neck Cancer StudiesLung Cancer Treatments and Mutations
Cited by 208
- Verified
EHT0202 in Alzheimers Disease: A 3-Month, Randomized, Placebo- Controlled, Double-Blind Study
Vellas, B., Sol, O., J. Snyder, P., Ousset, P.-J., Haddad, R., Maurin, M., Lemarie, J.-C., Desire, L., & P. Pando, M. (2011) · Current Alzheimer Research
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 133
- Verified
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors
Nassar, A. H., Adib, E., Abou Alaiwi, S., El Zarif, T., Groha, S., Akl, E. W., Nuzzo, P. V., Mouhieddine, T. H., Perea-Chamblee, T., Taraszka, K., et al. (2022) · Cancer Cell
Cancer Immunotherapy and BiomarkersCancer Genomics and Diagnostics
Cited by 121
- Verified
Screening for High Utilizing Somatizing Patients Using a Prediction Rule Derived From the Management Information System of an HMO: A Preliminary Study
Smith, R. C., Gardiner, J. C., Armatti, S., Johnson, M., Lyles, J. S., Given, C. W., Lein, C., Given, B., Goddeeris, J., Korban, E., et al. (2001) · Medical Care
Psychosomatic Disorders and Their TreatmentsChronic Disease Management Strategies
Cited by 19
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free